|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.930 CNY | -1.60% |
|
-3.33% | -22.24% |
| 04-28 | Shanghai RAAS Blood Products Q1 net profit down 44.2% Y/Y | RE |
| 04-28 | Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | ||||
| 833.31 | +35.5% | 28 | ||||||
| 288.95 | +11.48% | 19 | ||||||
| 2,096,122.22 | +57.37% | 23 | ||||||
| 96.81 | +29.52% | 16 | ||||||
| 220.13 | +10.82% | 30 | ||||||
| 109.09 | +6.97% | 23 | ||||||
| 43.3 | -16.94% | 20 | ||||||
| 101.64 | +51.86% | 26 | ||||||
| 471.67 | +8.43% | 12 | ||||||
| 275.28 | +8.63% | 21 | ||||||
| 102.71 | +51.05% | 23 | ||||||
| 464,000 | +32.95% | 5 | ||||||
| 87.85 | +57.85% | 26 | ||||||
| 322.78 | -0.61% | 9 | ||||||
| 14.52 | +59.78% | 12 | ||||||
| - | - | 40.3 | +42.1% | 1 | ||||
| 31.4 | +112.54% | 10 | ||||||
| - | - | 89.17 | +58.67% | 1 | ||||
| 72.5 | +28.32% | 2 | ||||||
| Average | 134,911.77 | +34.01% | 16 | ||||||
| Weighted average by Cap. | 235,967.4 | +28.19% | 20 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition